Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
PEPG
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?
PepGen Inc. (NASDAQ:PEPG) is one of the best NASDAQ stocks under $5 to buy right now. On May 12, PepGen reported Q1 2026 financial results, recording a net loss of $17.8 million, or $0.26 per share, compared to a net loss of $30.2 million…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.…
Catalyst Watch: Tesla talks AI5 chips, Intel reports, and the Warner Bros. deal goes to a vote
[Stock Exchange] ShinjiPhotographer Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - APRIL 20 * VOL…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.…
Catalyst Watch: Earnings heat up, Fedspeak flurry, and eyes on space
[Wall street and Broadway road sign in New York City] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDA…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.…
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of PepGen Inc. (NASDAQ: PEPG). The investigation focuses on whether PepGen or certain of its executives violated fe…
Cheap high flyer healthcare stocks - high momentum and low valuation
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season ramps up and geopolitical tensions keep affecting the markets, below is a list of the top 10 healt…
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
BOSTON, December 09, 2025--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular a…
Sarepta's Stock Rises on Positive Updates on DM1 Therapy
Shares of Sarepta Therapeutics SRPT rose 7% on Monday after the company announced its progress on a phase I/II study evaluating SRP-1003, an investigational small interfering RNA (siRNA) therapeutic for type 1 myotonic dystrophy (DM1). Whi…
* PepGen press release [https://seekingalpha.com/pr/20303312-pepgen-reports-third-quarter-2025-financial-results-and-recent-corporate-highlights] (PEPG [https://seekingalpha.com/symbol/PEPG]): Q3 GAAP EPS of -$0.52. * As of September 30, 2…
BofA Lifts PepGen (PEPG) PT to $3 on Positive DM1 Data Despite Underperform Rating
PepGen Inc. (NASDAQ:PEPG) is one of the hot stocks to buy with huge upside potential. On October 9, BofA raised the firm’s price target on PepGen to $3 from $1 and maintained an Underperform rating on the shares. This sentiment came out as…
PepGen Inc. (PEPG) Rating Upgraded With 135% Upside on FREEDOM Data
PepGen Inc. (NASDAQ:PEPG) is among the best fast money stocks to buy now. H.C. Wainwright has reaffirmed its ‘Buy’ rating on PepGen Inc. (NASDAQ:PEPG), while increasing the price target to $12.00 from $8.00, implying a surge of nearly 135%…
PepGen (PEPG) Skyrockets 121% on Stellar Experimental Treatment Trial Results
We recently published Massive Gains: 10 Stocks Investors Can’t Stop Buying. PepGen Inc. (NASDAQ:PEPG) is one of the top performers on Thursday. Shares of PepGen soared by 121.05 percent on Thursday to end at $5.88 apiece as investors cheer…
PepGen (PEPG) shares rose Thursday after the company said late Wednesday it achieved the highest mea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Sector Update: Health Care Stocks Decline Premarket Thursday
Health care stocks were declining premarket Thursday, with the Health Care Select Sector SPDR Fund ( PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
What Is Behind PepGen Stock Surging 115% In Premarket Trade?
(RTTNews) - Shares of PepGen Inc. (PEPG) were up over 115% at $5.74 in after-hours trading on Wednesday, following encouraging data from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 trial. FREEDOM-DM1 is a multinational, placebo-con…
* PepGen (NASDAQ:PEPG [https://seekingalpha.com/symbol/PEPG]) announced on Wednesday the pricing of an underwritten offering [https://seekingalpha.com/pr/20243779-pepgen-announces-pricing-of-100-million-public-offering] of 31.25M shares of…
IMRX Soars On Pancreatic Cancer Data, PEPG Sets DM1 Splicing Correction Record, CLPT On Watch
(RTTNews) - Several biotech stocks hit new highs during regular trading on Wednesday, with some extending their gains in after-hours trading. While positive trial results in myotonic dystrophy type 1 lifted PepGen in after-hours trading, a…
PepGen launches public offering to fund clinical trials; shares up 34%
* PepGen (NASDAQ:PEPG [https://seekingalpha.com/symbol/PEPG]) has initiated an underwritten public offering of common stock and pre-funded warrants. * All securities in the offering are being sold by PepGen, with a 30-day option for underw…
Biotech Stocks Surge After Hours On Trial Updates And Strategic Moves
(RTTNews) - After-hours trading on Tuesday featured a wave of notable price moves across the biotech and therapeutics space, with several small- and mid-cap names posting sharp gains following clinical updates, strategic announcements, or…
MODD, GALT, XCUR, PEPG, BSGM Stocks Pop After Hours On Clinical Updates And Strategic Moves
(RTTNews) - Several biotech stocks made sharp moves in after-hours trading on Thursday, September 11, 2025, driven by clinical updates, strategic pivots, and rebranding efforts. Here's a quick look at what sparked the action. Modular Medic…
(RTTNews) - Biotech stocks are showing renewed momentum, with several small-cap names posting notable after-hours gains and attracting investor attention. From insider buying and strategic partnerships to clinical trial progress and bold f…
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of PepGen Inc.(PEPG) Shareholders
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses…
PEPGEN (PEPG) FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds PepGen Investors of the August 8th Deadline and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In PepGen (PEPG) To Contact Them Directly To Discuss Their Options If you purchased or acquired securities in PepGen between March 7, 2024 and March 3…
Lost Money on PepGen Inc. (PEPG)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG). Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact th…
PepGen Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 8, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG) investors of a cla…
PepGen Inc. (NASDAQ:PEPG) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Legal Uncertainties
PepGen Inc. (NASDAQ:PEPG [https://www.chartmill.com/stock/quote/PEPG]) reported its second-quarter 2025 financial results, posting a net loss of $23.1 million, or $(0.70) per share, compared to a net loss of $28.3 million, or $(0.87) per s…
PEPG DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 8 Deadline in Securities Class Action – PEPG
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Pe…
PEPGEN (PEPG) URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds PepGen Investors of the August 8th Deadline and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In PepGen (PEPG) To Contact Them Directly To Discuss Their Options If you purchased or acquired securities in PepGen between March 7, 2024 and March 3…
PepGen Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; August 8, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG) investors of a cla…
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) and certain officers. The class action, filed in the United State…
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PepGen To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PepGen…
PepGen Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 8, 2025 to Discuss Your Rights – PEPG
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG). Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact th…
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PepGen Inc. (“PepGen” or “the C…
מועד אחרון לתביעה נגד PEPG: רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי PepGen Inc להשיג ייעוץ לפני המועד האחרון החשוב של 8 באוגוסט בתביעה ייצוגית בניירות ערך - PEPG
ניו יורק, Aug. 03, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של PepGen Inc. (נאסד"ק: PEPG) בין התאריכים 7במרץ2024 עד 3במרץ 2025, שני התא…